With reference to iNCOVACC, consider the following statements:
1. This is India’s first intranasal vaccine for COVID-19.
2. This new vaccine has been approved for primary immunisation and it can be administered only to the unimmunised.
3. The development of the vaccine was completely funded by the Department of Biotechnology’s Covid Suraksha programme.
4. It will enable faster development of variant-specific vaccines and easy nasal delivery that enables mass immunisation to protect from emerging variants of concern.
Which of the statements given above is/are correct?1
1, 2, and 3 only
2
1, 2, and 4 only
3
1, 2, 3, and 4
4
2, 3, and 4 only